• 1
    Bene MC, Castoldi G, Knapp W, Ludwig WD, Matutes E, Orfao A, van't Veer MB. Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL). Leukemia 1995; 9: 17831786.
  • 2
    Lanza F, Castoldi GL, Castagnari B, Todd RT III, Moretti S, Spisani S, Latorraca A, Bardi A, Traniello S. Expression and functional role of urokinase-type plasminogen activator receptor (UPA-R) in normal and acute leukemic cells. Br J Haematol 1998; 103: 110123.
  • 3
    Bellos F, Alpermann T, Gouberman E, Haferlach C, Schnittger S, Haferlach T, Kern W. Evaluation of flow cytometric assessment of myeloid nuclear differentiation antigen expression as a diagnostic marker for myelodysplastic syndromes in a series of 269 patients. Cytometry B Clin Cytom 2012; 82B: 295304.
  • 4
    Larsen A, Roug A, Just T, Brown G, and Hokland P. Expression of the hMICL in acute myeloid leukemia—A highly reliable disease marker at diagnosis and during follow-up. Cytometry B Clin Cytom 2012; 82: 38.
  • 5
    Knapp W, Strobl H, Majdic O. Flow cytometric analysis of cell-surface and intracellular antigens in leukemia diagnosis. Cytometry 1994; 18: 187198.
  • 6
    Lanza F, Moretti S, Latorraca A, Ferrari L, Castagnari B, Castoldi GL. Cytofluorimetric measurement of cytoplasmic myeloperoxidase by permeabilisation of blood cells with the FACS lysing solution. Cytometry 1996; 24: 292295.
  • 7
    Lanza F, Latorraca A, Moretti S, Castagnari B, Ferrari L, Castoldi GL. Comparative analysis of different permeabilization methods for the flow cytometry measurement of cytoplasmic MPO and lysozyme in normal and leukemic cells. Cytometry 1997; 30: 111
  • 8
    Dobrowolska H, Gill KZ, Serban G, Ivan E, Li Q, Qiao W, Suciu-Foca N, Savage D, Alobeid B, Bhagat G, Colovai AI. Expression of immune inhibitory receptor ILT3 in acute myeloid leukemia with monocytic differentiation. Cytometry B Clin Cytom 2013; 84B: 2129.
  • 9
    Frebet E, Abraham J, Genevieve F, Lepelley P, Daliphard S, Bardet V, Amsellem S, Guy J, Mullier F, Durrieu F, Venon M-D, Leleu X, Jaccard A, Faucher J-L, Be´ne´ MC, Feuillard, J; for the GEIL (Groupe d'Etude Immunologique des Leucemies) Study Group. A GEIL flow cytometry consensus proposal for quantification of plasma cells: Application to differential diagnosis between MGUS and myeloma. Cytometry B Clin Cytom 2011; 80B: 176185.
  • 10
    Paiva B, Almeida J, Pe´rez-Andre´s M, Mateo G, Lopez A, Rasillo A, Vıdriales M-B, Lo´pez-Berges M-C, San Miguel JF, Orfao A. Utility of flow cytometry immunophenotyping in multiple myeloma and other clonal plasma cell-related disorders. Cytometry B Clin Cytom 2010; 78B: 239252.
  • 11
    Johnsen HE, Bøgsted M, Klausen TW, Gimsing P, Schmitz A, Kjærsgaard E, Damgaard T, Voss P, Knudsen LM, Mylin AK, Nielsen JL, Bjo¨rkstrand B, Gruber A, Lenhoff S, Remes K, Dahl IM, Fogd K, and Dybkær K; Nordic Myeloma Study Group (NMSG) and the Myeloma Stem Cell Network (MSCNET). Multiparametric flow cytometry profiling of neoplastic plasma cells in multiple myeloma. Cytometry B Clin Cytom 2010; 78B: 338347.
  • 12
    Cannizzo E, Bellio E, Sohani AR, Hasserjian RP, Ferry JA, Dorn ME, Sadowski C, Bucci JJ, Carulli G, Preffer F. Multiparameter immunophenotyping by flow cytometry in multiple myeloma: The diagnostic utility of defining ranges of normal antigenic expression in comparison to histology. Cytometry B Clin Cytom 2010; 78B: 231238
  • 13
    van Velzen JF, van den Blink D, Bloem AC. Inability of a monoclonal anti-light chain antibody to detect clonal plasma cells in a patient with multiple myeloma by multicolor flow cytometry. Cytometry B Clin Cytom 2013; 84B: 3032 (this issue).
  • 14
    Hernandez-Campo PM, Almeida J, Sanchez ML, Malvezzi M, Orfao A. Normal Patterns of expression of glycosylphosphatidylinositol-anchored proteins on different subsets of peripheral blood cells: A frame of reference for the diagnosis of paroxysmal nocturnal hemoglobinuria. Cytometry B Clin Cytom 2006; 70: 7181.
  • 15
    Borowitz MJ, Craig FE, DiGiuseppe JA, Illingworth AJ, Rosse W, Sutherland DR, Wittwer CT, Richards SJ. Guidelines for the diagnosis and monitoring of paroxysmal nocturnal hemoglobinuria and related disorders by flow cytometry. Cytometry B Clin Cytom 2010; 78B: 211230.
  • 16
    Sutherland DR, Keeney M, Illingworth A. Practical guidelines for the high-sensitivity detection and monitoring of paroxysmal nocturnal hemoglobinuria clones by flow cytometry. Cytometry B Clin Cytom 2012; 82B: 195208.
  • 17
    Wang A, Pozdnyakova O, Jeffrey L. Detection of paroxymal nocturnal haemoglobinuria clones in patients with myelodisplastic syndromes and related bone marrow diseases, with emphasis on diagnostic pitfalls and caveats. Haematologica 2008; 94: 2937
  • 18
    Battiwalla M, Hepgur M, Pan D, McCarthy PL, Ahluwalia MS, Camacho SH, Starostik P, Wallace PK. Multiparameter flow cytometry for the diagnosis and monitoring of small GPI-deficient cellular populations. Cytometry B Clin Cytom 2010; 78B: 348356.
  • 19
    Herbert DJ, Miller DT, Bagwell CB. Automated analysis of flow cytometric data for CD34+ stem cell enumeration using a probability state model. Cytometry B Clin Cytom 2012; 82B: 313318.
  • 20
    Dalal BI, Khare NS. Flow cytometric testing for paroxysmal nocturnal hemoglobinuria: CD64 is better for gating monocytes than CD33. Cytometry B Clin Cytom 2013; 84B: 3336.
  • 21
    Warang P, Gupta M, Kedar P, Ghosh K, Colah R. Flow cytometric osmotic fragility—An effective screening approach for red cell membranopathies. Cytometry B Clin Cytom 2011; 80B: 186190.
  • 22
    Subira´ D, Uriel M, Serrano C, Castanon S, Gonzalo R, Illan J, Plaza J, Roman A. Significance of the volume of fetomaternal hemorrhage after performing prenatal invasive tests. Cytometry B Clin Cytom 2011; 80B: 3842.
  • 23
    Pastoret C, Le Priol J, Fest T, Roussel M. Evaluation of FMH QuikQuant for the detection and quantification of fetomaternal hemorrhage. Cytometry B Clin Cytom 2013; 84B: 3743.
  • 24
    Anuar TS, Al-Mekhlafi HM, Ghani MK, Osman E, Yasin AM, Nordin A, Azreen SN, Salleh FM, Ghazali N, Bernadus M, Moktar N. Giardiasis among different tribes of Orang Asli in Malaysia: Highlighting the presence of other family members infected with Giardia intestinalis as a main risk factor. Int J Parasitol 2012; 42: 871880.
  • 25
    Keserue HA, Füchslin HP, Egli T. Rapid detection and enumeration of Giardia lamblia cysts in water samples by immunomagnetic separation and flow cytometric analysis. Appl Environ Microbiol 2011; 77: 54205427.
  • 26
    Barbosa J, Costa-de-Oliveira S, Rodrigues AG, Pina-Vaz C. Optimization of a flow cytometry protocol for detection and viability assessment of Giardia lamblia. Travel Med Infect Dis 2008; 6: 234239.
  • 27
    El-Nahas HA, Salem DA, El-Henawy A, El-Nimr HI, Abdel Ghaffar HA. Giardia diagnostic methods in human fecal samples: A comparative study. Cytometry B Clin Cytom 2013; 84B: 4449.
  • 28
    Le N T, Chao N. Regulating regulatory T cells. Bone Marrow Transplant 2007; 39: 19.
  • 29
    Lanza F. Towards standardization of Foxp3+ regulatory T cells measurement for clinical use. Cytometry B Clin Cytom 2009; 68B: 6668
  • 30
    Onlamoon N, Sukapirom K, Polsrila K, Ammaranond P, Pattanapanyasat K. Alteration of CD8+ T cell effector diversity during HIV-1 infection with discordant normalization in effective antiretroviral therapy. Cytometry B Clin Cytom 2012; 82B: 3542.
  • 31
    Grant J, Bourcier K, Wallace S, Pan D, Conway A, Seyfert-Margolis V, Wallace PK. Validated protocol for FoxP3 reveals increased expression in Type 1 diabetes patients. Cytometry B Clin Cytom 2009; 76B: 6978.
  • 32
    Sattui S, de la Flor C, Sanchez C, Lewis D, Lopez G, Rizo-Patro´n E, White AC Jr, Montes M. Cryopreservation modulates the detection of regulatory T cell markers. Cytometry B Clin Cytom 2012; 82B: 5458.
  • 33
    Saison J, Demaret J, Venet F, Chidiac C, Malcus C, Poitevin-Later F, Tardy JC, Ferry T, Monneret G. CD4+ CD25+ CD127- assessment as a surrogate phenotype for FOXP3+ regulatory T cells in HIV-1 infected viremic and aviremic subject. Cytometry B Clin Cytom 2013; 84B: 5054.
  • 34
    Mojumdar K, Vajpayee M, Chauhan NK, Singh A, Singh R, Kurapati S. Altered T cell differentiation associated with loss of CD27 and CD28 in HIV infected Indian individuals. Cytometry B Clin Cytom 2012; 82B: 4353.
  • 35
    Wagner TA, Lin CH, Tobin NH, Côtè H, Sloan DD, Jerome KR, Frenkel LM. Quantification of mitochondrial toxicity in HIV- infected individuals by quantitative PCR compared to flow cytometry. Cytometry B Clin Cytom 2013; 84B: 5558.
  • 36
    Riccardi F, Della Porta MG, Rovati B, Casazza A, Radolovich D, De Amici M, Danova M, Langer M. Flow cytometric analysis of peripheral blood dendritic cells in patients with severe sepsis. Cytometry B Clin Cytom 2011; 80B: 1421.
  • 37
    Roussel M, Gros A, Gacouin A, Le Meur N, Le Tulzo Y, Fest T. Toward new insights on the white blood cell differential by flow cytometry: A proof of concept study on the sepsis model. Cytometry B Clin Cytom 2012; 82B: 345352.
  • 38
    Demaret J, Walencik A, Jacob MC, Timsit JF, Venet F, Lepape A, Monneret G. Inter-laboratory assessment of flow cytometric monocyte HLA-DR expression in clinical samples. Cytometry B Clin Cytom 2013; 84B: 5962.